# Merck opens meglumine production facility in Mollet del Vallès, Spain

Merck announced the opening of a facility in Mollet del Vallès, Spain, dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.

- Type: New facility
- Announced: 2017-01-18
- Where: Mollet del Vallès, Spain
- Starts operating: 12 Jan 2017
- Status: completed
- Products: meglumine
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)

## Sources

- [kyodonewsprwire.jp](https://kyodonewsprwire.jp/release/201701187996), 2017-01-18: "Merck today announced the opening of a facility in Mollet des Valles, Spain dedicated to the manufacture of meglumine."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.